US Patent Issued to UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA on Jan. 27 for "Target to treat a metabolic disease in an individual" (Spanish Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,727, issued on Jan. 27, was assigned to UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (Vizcaya, Spain).

"Target to treat a metabolic disease in an individual" was invented by Patricia Aspichueta Celaa (Leioa-Vizcaya, Spain), Xabier Buque Garcia (Leioa-Vizcaya, Spain) and Diego Saenz de Urturi (Leioa-Vizcaya, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, compounds, and compositions for reducing expression of MAT1a in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease or disorder in an individual."

The patent was filed on...